siRNAs protect against fulminant hepatitis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1387, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

siRNAs: in vitro activity against SARS virus

By  

Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

siRNAs inhibit HIV-1 virus infection

By  

Inpharma, Vol. 1, Iss. 1350, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

PTD/CPP Peptide-Mediated Delivery of siRNAs

By  

Current Pharmaceutical Design, Vol. 19, Iss. 16, 2013-05 ,pp. : 2943-2947

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Chemically Modified siRNAs

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 7, 2010-06 ,pp. : 578-595

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Nucleic Acid-Based Agents: siRNAs and miRNAs

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 8, Iss. 2, 2008-06 ,pp. : 121-130

Bentham Science Publishers

Access to resources Recommend Favorite